Smart Cancer Drug RK-251
Recently, Indian researchers have developed RK-251, an experimental cancer drug designed to activate in cancer cells with high levels of reactive oxygen species (ROS), potentially improving treatment selectivity.
What is RK-251?
- Smart Drug: RK-251 is an experimental activatable prodrug designed to remain relatively inactive until it encounters high ROS levels.
- Cancer Targeting: It exploits the higher oxidative stress often found in cancer cells.
- Molecular Switch: Elevated ROS triggers a chemical change that activates the drug.
- Active Compound: Activation releases NBDHEX, the anticancer compound responsible for the therapeutic effect.
How Does RK-251 Work?
- ROS Detection: Cancer cells with elevated ROS ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Reusable Rocket Stage Recovery by China
- 2 Bio-Inspired Coating for 3D-Printed Bone Implants
- 3 IUCAA Discovers X-ray Binary System in Magellanic Bridge
- 4 IARC Classifies Three Common Medicines as Group 1 Carcinogens
- 5 Moken Sea Nomads and Underwater Vision
- 6 India’s First Indigenous African Swine Fever Vaccine
- 7 800 kN FFSC Rocket Engine
- 8 Mandatory Vehicle-to-Vehicle Communication
- 9 Thunderquakes: Using Thunder to Map the Earth’s Subsurface
- 10 AI Designs Complete Viral Genomes to Fight Drug-Resistant Bacteria

